Matches in DBpedia 2016-04 for { <http://dbpedia.org/resource/Drotrecogin_alfa> ?p ?o }
- Drotrecogin_alfa abstract "Drotrecogin alfa (activated) (Xigris, marketed by Eli Lilly and Company) is a recombinant form of human activated protein C that has anti-thrombotic, anti-inflammatory, and profibrinolytic properties. Drotrecogin alpha (activated) belongs to the class of serine proteases. Drotrecogin alfa has not been found to improve outcomes in people with severe sepsis. The manufacturer's aggressive strategies in marketing its use in severe sepsis have been criticized. On October 25, 2011, Eli Lilly & Co. withdrew Xigris from the market after a major study showed no efficacy for the treatment of sepsis.".
- Drotrecogin_alfa atcPrefix "B01".
- Drotrecogin_alfa atcSuffix "AD10".
- Drotrecogin_alfa bioavailability "100.0".
- Drotrecogin_alfa casNumber "60202-16-6".
- Drotrecogin_alfa drugbank "DB00055".
- Drotrecogin_alfa iupacName "Activated human protein C".
- Drotrecogin_alfa wikiPageExternalLink xigris_USPI_17Dec04.pdf.
- Drotrecogin_alfa wikiPageExternalLink www.xigris.com.
- Drotrecogin_alfa wikiPageID "1707323".
- Drotrecogin_alfa wikiPageLength "14302".
- Drotrecogin_alfa wikiPageOutDegree "27".
- Drotrecogin_alfa wikiPageRevisionID "691418212".
- Drotrecogin_alfa wikiPageWikiLink APACHE_II.
- Drotrecogin_alfa wikiPageWikiLink Anti-inflammatory.
- Drotrecogin_alfa wikiPageWikiLink Aspirin.
- Drotrecogin_alfa wikiPageWikiLink Brand.
- Drotrecogin_alfa wikiPageWikiLink Category:Antithrombotic_enzymes.
- Drotrecogin_alfa wikiPageWikiLink Category:Eli_Lilly_and_Company.
- Drotrecogin_alfa wikiPageWikiLink Category:Intensive_care_medicine.
- Drotrecogin_alfa wikiPageWikiLink Category:Withdrawn_drugs.
- Drotrecogin_alfa wikiPageWikiLink Clopidogrel.
- Drotrecogin_alfa wikiPageWikiLink Cochrane_(organisation).
- Drotrecogin_alfa wikiPageWikiLink Eli_Lilly_and_Company.
- Drotrecogin_alfa wikiPageWikiLink Food_and_Drug_Administration.
- Drotrecogin_alfa wikiPageWikiLink Plasminogen_activator_inhibitor-1.
- Drotrecogin_alfa wikiPageWikiLink Protein_C.
- Drotrecogin_alfa wikiPageWikiLink Recombinant_DNA.
- Drotrecogin_alfa wikiPageWikiLink Selectin.
- Drotrecogin_alfa wikiPageWikiLink Sepsis.
- Drotrecogin_alfa wikiPageWikiLink Serine_protease.
- Drotrecogin_alfa wikiPageWikiLink The_New_England_Journal_of_Medicine.
- Drotrecogin_alfa wikiPageWikiLink Thrombosis.
- Drotrecogin_alfa wikiPageWikiLink Tumor_necrosis_factors.
- Drotrecogin_alfa wikiPageWikiLink Warfarin.
- Drotrecogin_alfa wikiPageWikiLink White_blood_cell.
- Drotrecogin_alfa wikiPageWikiLinkText "Drotrecogin alfa".
- Drotrecogin_alfa wikiPageWikiLinkText "Drotrecogin alfa-activated".
- Drotrecogin_alfa wikiPageWikiLinkText "Xigris".
- Drotrecogin_alfa wikiPageWikiLinkText "drotrecogin alfa".
- Drotrecogin_alfa wikiPageWikiLinkText "drotrecogin alfa-activated".
- Drotrecogin_alfa atcPrefix "B01".
- Drotrecogin_alfa atcSuffix "AD10".
- Drotrecogin_alfa bioavailability "100.0".
- Drotrecogin_alfa c "1786".
- Drotrecogin_alfa casNumber "60202".
- Drotrecogin_alfa chemspiderid "none".
- Drotrecogin_alfa drugbank "DB00055".
- Drotrecogin_alfa eliminationHalfLife "7200.0".
- Drotrecogin_alfa h "2779".
- Drotrecogin_alfa iupacName "Activated human protein C".
- Drotrecogin_alfa iupharLigand "6788".
- Drotrecogin_alfa legalStatus "Rx-only, not a controlled substance".
- Drotrecogin_alfa metabolism "endogenous plasma protease inhibitors".
- Drotrecogin_alfa molecularWeight "55000".
- Drotrecogin_alfa n "509".
- Drotrecogin_alfa o "519".
- Drotrecogin_alfa pregnancyCategory "C".
- Drotrecogin_alfa routesOfAdministration "i.v. application only".
- Drotrecogin_alfa s "29".
- Drotrecogin_alfa verifiedrevid "457450996".
- Drotrecogin_alfa wikiPageUsesTemplate Template:Antithrombotics.
- Drotrecogin_alfa wikiPageUsesTemplate Template:Cascite.
- Drotrecogin_alfa wikiPageUsesTemplate Template:Chemspidercite.
- Drotrecogin_alfa wikiPageUsesTemplate Template:Citation_needed.
- Drotrecogin_alfa wikiPageUsesTemplate Template:Drugbankcite.
- Drotrecogin_alfa wikiPageUsesTemplate Template:Drugbox.
- Drotrecogin_alfa wikiPageUsesTemplate Template:Drugs.com.
- Drotrecogin_alfa wikiPageUsesTemplate Template:Intensive_care_medicine.
- Drotrecogin_alfa wikiPageUsesTemplate Template:Official_website.
- Drotrecogin_alfa wikiPageUsesTemplate Template:Reflist.
- Drotrecogin_alfa wikiPageUsesTemplate Template:Nurses_Drug_Handbook_-_Jones_and_Bartlett_Learning.
- Drotrecogin_alfa subject Category:Antithrombotic_enzymes.
- Drotrecogin_alfa subject Category:Eli_Lilly_and_Company.
- Drotrecogin_alfa subject Category:Intensive_care_medicine.
- Drotrecogin_alfa subject Category:Withdrawn_drugs.
- Drotrecogin_alfa hypernym Form.
- Drotrecogin_alfa type Agent.
- Drotrecogin_alfa type ChemicalSubstance.
- Drotrecogin_alfa type Company.
- Drotrecogin_alfa type Drug.
- Drotrecogin_alfa type Agent.
- Drotrecogin_alfa type Chemical.
- Drotrecogin_alfa type Company.
- Drotrecogin_alfa type Drug.
- Drotrecogin_alfa type Redirect.
- Drotrecogin_alfa type Specialty.
- Drotrecogin_alfa type ChemicalObject.
- Drotrecogin_alfa type Thing.
- Drotrecogin_alfa type Q8386.
- Drotrecogin_alfa comment "Drotrecogin alfa (activated) (Xigris, marketed by Eli Lilly and Company) is a recombinant form of human activated protein C that has anti-thrombotic, anti-inflammatory, and profibrinolytic properties. Drotrecogin alpha (activated) belongs to the class of serine proteases. Drotrecogin alfa has not been found to improve outcomes in people with severe sepsis. The manufacturer's aggressive strategies in marketing its use in severe sepsis have been criticized. On October 25, 2011, Eli Lilly & Co.".
- Drotrecogin_alfa label "Drotrecogin alfa".
- Drotrecogin_alfa sameAs Q412888.
- Drotrecogin_alfa sameAs Drotrecogin.
- Drotrecogin_alfa sameAs Drotrekogina_alfa.
- Drotrecogin_alfa sameAs Drotrecogina_alfa.
- Drotrecogin_alfa sameAs m.05p_w4.
- Drotrecogin_alfa sameAs Drotrekogin_alfa.
- Drotrecogin_alfa sameAs Drotrekogin_alfa.
- Drotrecogin_alfa sameAs Drotrecogin_alfa.